Cancer Treatment Market Research Reports & Industry Analysis
Cancer is a disease characterized by uncontrolled cell proliferation. Of the more than 100 types of cancer, lung, breast, and colorectal cancer account for nearly half of new cases per year in the United States. Lung cancer, which is highly correlated with cigarette smoking, is responsible for more deaths than any other form of cancer. Cigarette smoking and other environmental factors are associated with the majority of cancers.
With the growing incidence of cancer, a growing and aging world population and significant medical advances, there will continue to be phenomenal growth in the market for cancer diagnosis and treatment products.
Cancer Treatment Industry Research & Market Reports
-
APAC Thyroid Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... Carcinoma, Follicular Carcinoma, Others), Stages (Stage I, Stage II, Stage III, Stage IV), Age Group (30-65, 65 and Above, 21-29, Below 21), End Users (Hospital, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research ... Read More
-
NA Kidney Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... Stage II, Stage III and Stage IV), Tumor Type (Renal Cell Carcinoma, Clear cell renal cell carcinoma, non-clear cell renal cell carcinoma), Product (Platform-Based Products, Instrument based products, Kits and Reagents, and Other Consumables), Technology ... Read More
-
MEA Breast Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... Carcinoma, Invasive Ductal Carcinoma, Inflammatory Breast Cancer, and Metastatic Breast Cancer), End User (Hospitals, Clinics, Research and Academic Institutes, Diagnostic Centres, and Others) Distribution Channel (Direct Tender, Retail Sales, and Others), Country (South Africa, Saudi ... Read More
-
MEA Thyroid Cancer Diagnostics Market - Industry Trends and Forecast to 2030
... Cancer Type (Papillary Carcinoma, Follicular Carcinoma, Others), Stages (Stage I, Stage II, Stage III, Stage IV), Age Group (30-65, 65 and Above, 21-29, Below 21), End Users (Hospital, Associated Labs, Independent Diagnostic Laboratories, Diagnostic Imaging ... Read More
-
B-Cell Non-Hodgkins Lymphoma Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
... 10-year patient-based forecast (PBF) across the eight major pharmaceutical markets (8MM) (US, France, Germany, Italy, Spain, UK, Japan, and China) for marketed and pipeline therapies with established mechanisms of action by class, including early to ... Read More
-
NGS Informatics Market - A Global and Regional Analysis: Focus on Products and Services, Application, End User, and Region - Analysis and Forecast, 2022-2032
... was valued at $1,380.0 million in 2021 and is projected to reach $6,715.0 million by the end of 2032. The market is expected to grow at a CAGR of 15.21% during the forecast period 2022-2032. ... Read More
-
Interleukin 1 Receptor Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Associated Kinase 4 (Renal Carcinoma Antigen NY REN 64 or IRAK4 or EC 2.7.11.1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Interleukin 1 Receptor Associated Kinase ... Read More
-
Merkel Cell Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Merkel Cell Carcinoma - Drugs In Development, 2022, provides an overview of the Merkel Cell Carcinoma (Oncology) pipeline landscape. Merkel cell carcinoma is ... Read More
-
Colon Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colon Cancer - Drugs In Development, 2022, provides an overview of the Colon Cancer (Oncology) pipeline landscape. Colon cancer is cancer that starts in the ... Read More
-
Multiple Myeloma (Kahler Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Multiple Myeloma (Kahler Disease) - Drugs In Development, 2022, provides an overview of the Multiple Myeloma (Kahler Disease) (Oncology) pipeline landscape. ... Read More
-
Non-Small Cell Lung Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Non-Small Cell Lung Cancer - Drugs In Development, 2022, provides an overview of the Non-Small Cell Lung Cancer (Oncology) pipeline landscape. ... Read More
-
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Drugs In Development, 2022, provides an overview ... Read More
-
Bile Duct Cancer (Cholangiocarcinoma) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Bile Duct Cancer (Cholangiocarcinoma) - Drugs In Development, 2022, provides an overview of the Bile Duct Cancer (Cholangiocarcinoma) (Oncology) pipeline landscape. ... Read More
-
Kidney Cancer (Renal Cell Cancer) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... and Key Players, 2022 Update Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Kidney Cancer (Renal Cell Cancer) - Drugs In Development, 2022, provides an overview of the Kidney Cancer (Renal Cell ... Read More
-
Colorectal Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Colorectal Cancer - Drugs In Development, 2022, provides an overview of the Colorectal Cancer (Oncology) pipeline landscape. Colorectal cancer is a cancer that starts in ... Read More
-
Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
... Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ovarian Cancer - Drugs In Development, 2022, provides an overview of the Ovarian Cancer (Oncology) pipeline landscape. Ovarian cancer is any cancerous growth that may ... Read More
-
U.S. Prostate Cancer Testing Market - A Country Analysis: Focus on Type of Biomarker, Application, End User, and Region - Analysis and Forecast, 2022-2030
... testing market is anticipated to reach $1,901.6 million in 2030 from $544.1 million in 2021, with a CAGR of 14.7%, during the forecast period 2022-2030. The growth in the U.S. prostate cancer testing market is ... Read More
-
Global Prostate Cancer Testing Market - A Regional and Country Analysis: Focus on Test Type, Application, End User, and Region - Analysis and Forecast, 2022-2032
... global prostate cancer testing market was valued at $5,246.9 million, and it is expected to reach $21,306.9 million by 2032, growing at a CAGR of 13.68% during the forecast period 2022-2032. The growth in the ... Read More
-
Colorectal Cancer Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
... patient-based forecast (PBF) across the 8MM for marketed and pipeline therapies with established mechanisms of action and cell therapies by class, including early to late clinical stage pipeline products, with a launch date assessment by ... Read More
-
Prostate Cancer Minimally Invasive Surgery Market (Procedure: Laparoscopic Surgery, Robotic Surgery, Radiation Therapy, Cryosurgery, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2022-2031
... of Report TMR’s report on the global prostate cancer minimally invasive surgery market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market ... Read More
-
Liver Cancer Diagnostics Market Size, Share & Trends Analysis Report By Test Type (Laboratory Tests, Imaging, Endoscopy, Biopsy), By End-use, By Region, And Segment Forecasts, 2023 - 2030
... The global liver cancer diagnostics market size is expected to reach USD 14.67 billion by 2030, advancing at a CAGR of 6.67% over the forecast period from 2023 to 2030, according to a new report ... Read More
-
Acute Myeloid Leukemia Market Size and Trend Report including Epidemiology, Disease Management, Pipeline Analysis, Competitor Assessment, Unmet Needs, Clinical Trial Strategies and Forecast, 2021-2031
... 10-year patient-based forecast (PBF) across the 8MM for marketed and pipeline therapies with established mechanisms of action and cell therapies by class, including early to late clinical stage pipeline products, with a launch date assessment ... Read More
-
2023 Global Forecast for Cancer Gene Therapy (2024-2029 Outlook)-High Tech & Emerging Markets Report
... The global market is expected to increase from USD xx billion in 2024 to USD xx billion by 2029, at a CAGR of xx% from 2024 to 2029. Estimates on equipment or material sales (product ... Read More
-
2023 Global Forecast for Breast Cancer Liquid Biopsy Market (2024-2029 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The global market is expected to increase from USD xx billion in 2024 to USD xx billion by 2029, at a CAGR of xx% from 2024 to 2029. Estimates on equipment or material ... Read More
-
Cell Culture Market by Product [Consumables (Media, Reagents, Sera, Cell Lines), Equipment (Bioreactor, Centrifuge, Cell Counter)], Application (Bioproduction, Cancer Research, Stem Cell, Diagnostic), and End User (Pharma, Academic) - Global Forecast to 2029
... Market by Product [Consumables (Media, Reagents, Sera, Cell Lines), Equipment (Bioreactor, Centrifuge, Cell Counter)], Application (Bioproduction, Cancer Research, Stem Cell, Diagnostic), and End User (Pharma, Academic) - Global Forecast to 2029 The cell culture market ... Read More
Research Assistance
